Betterhealth Naturopathic Clinic

Want to find out my availability, pricing or opening hours? Click on Send Me Details Now to get started.

Send Me Details Now

Clicking on the Send Me Details Now button opens an enquiry form where you can message Betterhealth Naturopathic Clinic directly

Low-Level Laser Therapy Unit (LTU-904) pain & scarring

Betterhealth Clinic - Laser Therapy - Totally Painless

Servicing area

Joondalup and Northern Perth suburbs

Focus areas

Type 2 diabetes Arthritis Colitis Eczema Feeding Hormonal imbalance

On December 8, the FDA approved a low-level laser therapy unit (LTU-904, made by RianCorp Pty Ltd) for use in the treatment of postmastectomy lymphedema. According to a company news release, lymphedema has a US prevalence of approximately 3 million, affecting as many as 30% of postmastectomy patients. The chronic condition is caused by the effects of breast surgery on the lymphatic system that prevent drainage and result in limb swelling.

The handheld, battery-powered, nonthermal device delivers a controlled series of 200 ns bursts of near-infrared 904 nm laser-beam pulses that yield photochemical reactions at the cellular level, thereby influencing the course of metabolic processes. Designated as a class 1 laser, the unit is eye-safe for patients and clinicians.

According to company information, advantages associated with the laser's use include painless and often immediate analgesic effects at the time of treatment and a shortened recovery time with rapid reduction of inflammation.

The approval was based in part on data from a placebo-controlled, double-blind clinical trial of 64 patients in Australia who received active treatment or placebo three times weekly for two 3-week blocks.

Results at 6 weeks showed that 52% of laser-treated patients experienced clinically significant decreases in extracellular fluid levels compared with 19% of those receiving placebo; the number of patients achieving a 200 mL or greater decrease in limb volume was also higher (31% vs placebo, 4%). Improvements continued to progress during a 3-month follow-up period with no further treatment.

The laser therapy unit was previously approved in Australia, where it has been marketed for this indication since 2000.

This page cited from article: Yael Waknine . FDA Approvals: LTU-904, ORTHO T. cruzi, Paragon Z CRT. Medscape. Dec 18, 2006.

What other conditions may benefit?

  • Fibromyalgia
  • Neck and back pain
  • Injuries (achilles, sprains & swelling)
  • Post-surgery (stiffness & scar-tissue - particularly after mastectomy)
  • Fluid retention
  • Rosacea
  • Lack of energy
  • Acne scars (products may be recommended/needed)
  • Facial discolouration


Click on Send Me Details Now to get started

Send Me Details Now

Service categories